# MARKET_RESEARCH_LOG_2026-08-26

> Production V3.1 hourly scan handoff. Repository `main` remains the source of truth. This log records the latest completed production artifacts available to this run and must not be interpreted as an automatic trading instruction.

## 2026-08-26 01:10 CST — hourly production scan

### Canonical rules / data provenance

- Repository rules read from latest `main`: `AGENTS.md`, `CURRENT_MARKET_RESEARCH.md`, `RESEARCH_QUEUE.md`, `MODEL_EVOLUTION_LOG.md`, and current V3.1 production workflow/configuration.
- Production workflow status: latest `V3.1 Every-Industry Research` run inspected by this scan completed successfully (`run_id=32873471270`, run #51); latest Postscan research artifact in the same production cycle also completed and was inspected (`run_id=32873471268`).
- Latest verified A-share trade date in the valuation/quant artifacts: `2026-08-25`.
- Price freshness: `FRESH` for the latest completed production artifact where `latest_trade_date/qfq_latest_trade_date/raw_latest_trade_date=2026-08-25`; stale/unverified prices remain prohibited from producing Formal BUY.
- Execution-universe policy: only execution-eligible Shanghai/Shenzhen A shares may become actual buy candidates. Research-only codes remain excluded from Formal BUY.

### Production funnel

- Industry coverage: 83 industries, 383 industry candidates; 82 industries had a clean candidate.
- Frozen V3.1 deep-review queue: 375 names.
- Execution-universe eligible within the review queue: 294; research-only: 81.
- `v31_candidate_class`: all 375 are `PENDING`.
- `v31_a_eligible=true`: **0**.
- `v31_buy_ready=true`: **0**.
- Long-term second-pass candidates: 3 (`603658 安图生物`, `688526 科前生物`, `688687 凯因科技`), but all remain blocked from long-term Formal BUY under the frozen V3.1 contract.
- Postscan master research ranking: 399 names; `actionable_long_term_count=0`.
- Long-term Formal BUY: **0**; BUY-ready: **0**; TRY-position: **0**.
- No automatic promotion and no automatic trading are permitted by the inspected artifacts.

### A1 / A2 / WATCH / WAIT / INVALIDATED

- **A1:** 0 new executable names.
- **A2:** 0 new executable names.
- **WATCH:** research queue remains broad; no WATCH name was promoted into A1/A2 in this run.
- **WAIT:** all production names that look technically/valuation-interesting but lack completed evidence-backed V3.1 hard gates remain WAIT / research-required rather than BUY.
- **INVALIDATED:** no new thesis invalidation or forced-exit event was identified by the inspected production artifacts.

### Nearest-looking blocked names are not Formal BUY

`603658 安图生物` is execution-universe eligible and the postscan layer shows an entry-condition-present review state around a verified current price of 34.17 with an indicated entry band 33.58–34.15. It is **not** Formal BUY because the frozen V3.1 evidence layer still has unresolved/unknown hard gates (predictability, long-term demand, moat, financial safety, earnings authenticity), A-class is not proven, scenario valuation / expectation-gap / downside / falsification work is incomplete, and `v31_buy_ready=false`.

`688526 科前生物` and `688687 凯因科技` are additionally `RESEARCH_ONLY` for execution-universe purposes and therefore cannot become actual buy candidates for this user even before the remaining V3.1 evidence blockers are resolved.

### Valuation / buy-band changes

- No A1/A2 valuation range or executable buy range was created or materially changed in this run.
- Any pre-existing manual/working valuation examples in `CURRENT_MARKET_RESEARCH.md` remain prior research context only; they are not promoted by this production scan.
- No threshold was relaxed to manufacture a BUY.

### Rejections / blockers

The dominant reason no Formal BUY exists is not merely price. The frozen V3.1 review queue remains fail-closed when required qualitative and valuation evidence is incomplete. Typical blockers include:

- hard-gate evidence unknown/incomplete for predictability, long-term demand, moat, financial safety, or earnings authenticity;
- A-class not proven / V3.1 score incomplete;
- normalized profit / Bear-Base-Bull scenario valuation incomplete;
- implied expectation / expectation gap incomplete;
- risk-adjusted 3Y CAGR / downside / falsification incomplete;
- clear margin-of-safety and other Formal BUY conditions not proven;
- execution-universe blocked for research-only names.

### Delta versus prior handoff / latest production state

- Freshness improved versus the old durable handoff that warned exact current prices were unverified: the latest production artifact is explicitly dated to the 2026-08-25 trade date.
- This freshness improvement did **not** create an executable opportunity: A-eligible remains 0 and Formal BUY remains 0.
- No new A1/A2 promotion, no material buy-band change, no hard-logic invalidation, and no production/CI failure were found in this run.

### Confidence / reproducibility

- Scan-result confidence: **HIGH** for the statement that there is currently no production-grade Formal BUY in the inspected latest completed artifacts.
- Candidate-level fundamental/valuation confidence remains intentionally lower where frozen V3.1 evidence is incomplete; those names stay PENDING/WAIT.
- Reproduction anchors: production run `32873471270`, postscan run `32873471268`, latest trade date `2026-08-25`, policy `selection_framework_v3_1_frozen` / `long_term_formal_buy_v2_v31_frozen`.

### Formal BUY

**Formal BUY = NONE.**
